Status:
UNKNOWN
Digital 3D Breast Tomosynthesis Versus 2D in Clinical Evaluation of High Risk Women
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Breast Cancer
Eligibility:
FEMALE
40-90 years
Brief Summary
Patients with a higher breast cancer risk (higher than 17% according to the IBIS calculation) will receive a 2D digital mammography together with a 3D tomosynthesis (so called combo tomo) of both brea...
Eligibility Criteria
Inclusion
- women
- more than 17% risk for breast cancer (IBIS calculation)
- \> 40y old
Exclusion
- \< 40y old
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2017
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT02209129
Start Date
August 1 2014
End Date
August 1 2017
Last Update
August 5 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZLeuven
Leuven, Belgium, 3000